[1] |
CAZZOLA M. Myelodysplastic syndromes[J]. N Engl J Med, 2020, 383(14):1358-1374.
DOI
URL
|
[2] |
LIM K H, TEFFERI A, LASHO T L, et al. Systemic mastocytosis in 342 consecutive adults:survival studies and prognostic factors[J]. Blood, 2009, 113(23):5727-5736.
DOI
URL
|
[3] |
邵宇, 王健民, 龚胜兰, 等. 一种基于单核苷酸多态性位点的定量检测异基因造血干细胞移植后嵌合率的新方法[J]. 中华血液学杂志, 2010, 31(2):92-96.
|
[4] |
ARBER D A, ORAZI A, HASSERJISAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20) :2391-2405.
DOI
PMID
|
[5] |
SWERDLOWS H, CAMPO E, HARRIS N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Lyon: IARC Press, 2008.
|
[6] |
VALENT P, SOTLAR K, DPERR W R,et al. Refined diagnostic criteria and classification of mast cell leukemia(MCL) and myelomastocytic leukemia(MML):a consensus proposal[J]. Ann Oncol, 2014, 25(9):1691-1700.
DOI
URL
|
[7] |
SPERR W R, ESCRIBANO L, JORDAN J H, et al. Morphologic properties of neoplastic mast cells:delineation of stages of maturation and implication for cytological grading of mastocytosis[J]. Leuk Res, 2001, 25(7):529-536.
DOI
URL
|
[8] |
HÄGGLUND H, YAVUZ A S, DREIMANE A, et al. Graft-versus-mastocytosis effect after donor lymphocyte infusion:proof of principle[J]. Eur J Haematol, 2021, 106(2):290-293.
DOI
URL
|
[9] |
BAE M H, KIM H K, PARK C J, et al. A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation[J]. Ann Lab Med, 2013, 33(2):125-129.
DOI
PMID
|
[10] |
STOECKER M M, WANG E. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease:a clinicopathologic review[J]. Arch Pathol Lab Med, 2012, 136(7):832-838.
DOI
URL
|
[11] |
KIM M J, KIM M K, KIM Y K, et al. Systemic mastocytosis associated with acute myeloid leukaemia[J]. Pathology, 2017, 49(6):652-654.
DOI
URL
|
[12] |
CRAIG J W, HASSERJIAN R P, KIM A S, et al. Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis[J]. Mod Pathol, 2020, 33(6):1135-1145.
DOI
URL
|
[13] |
FRITSCHE-POLANZ R, FRITZ M, HUBER A, et al. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V[J]. Mol Oncol, 2010, 4(4):335-346.
DOI
URL
|
[14] |
JAWHAR M, DÖHNER K, KREIL S, et al. KIT D816 mutated/CBF-negative acute myeloid leukemia:a poor-risk subtype associated with systemic mastocytosis[J]. Leukemia, 2019, 33(5):1124-1134.
DOI
|
[15] |
NAGAI S, ICHIKAWAM, TAKAHASHI T, et al. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia[J]. Exp Hematol, 2007, 35(11):1747-1752.
PMID
|
[16] |
PULLARKAT V, BEDELL V, KIM Y, et al. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone[J]. Leuk Res, 2007, 31(2):261-265.
DOI
URL
|
[17] |
SPERR W R, DRACH J, HAUSWIRTH A W, et al. Myelomastocytic leukemia:evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation[J]. Clin Cancer Res, 2005, 11(19 Pt 1):6787-6792.
DOI
URL
|
[18] |
CHEN T, CHEN J, HUANG W, et al. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation[J]. Bone Marrow Transplant, 2003, 32(1):111-114.
DOI
|